CathWorks has received a new CPT code 0523T for its non-invasive, 3D FFRangio system, which is designed to assess atherosclerotic stenoses during coronary angiography interventions. A press release reports that the code issuance is a major step forward in helping physicians objectively and cost-effectively determine if percutaneous coronary intervention (PCI) is indicated in every coronary angiography procedure.
The CathWorks FFRangio system is a non-invasive fractional flow reserve (FFR) platform that aims to quickly and precisely delivers objective multivessel physiologic measurements to cost-effectively optimize and confirm intraprocedural PCI therapy decisions.
CPT code 0523T enables healthcare providers using the CathWorks FFRangio system to be reimbursed for: intraprocedural coronary FFR with 3D functional mapping of colour-coded FFR values for the entire coronary tree, derived from coronary angiogram data, that allow real-time review and interpretation of possible atherosclerotic stenosis(es) intervention.
CathWorks CEO Jim Corbett says: “CPT code 0523T approval is a very important step for our company and the market. The CPT code decision also reflects the long-term clinical importance of objective FFR-based PCI decision-making. Creating a long-term reimbursement solution to support intraprocedural FFRangio will enable physicians, patients, and payers to realize the proven clinical and economic benefits of FFR on an every-case basis.”
The CathWorks FFRangio system is in development and is not yet FDA cleared.